Research Articles | Page 11 | Aplastic Anemia and MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Datesort descending Journal Bone Marrow Disease
Clinical results with the DNA hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in patients with myelodysplastic syndromes: an update Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndromes Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
The Non-transplant Treatment of Myelodysplastic Syndromes-What's on the Horizon? Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Counselling and adverse event management for patients with myelodysplastic syndromes undergoing azacitidine therapy: a practice standard for Canadian nurses Oct 2012 Can Oncol Nurs J myelodysplastic syndromes (MDS)
Myelodysplastic syndrome hematopoietic stem cell Oct 2012 Int J Cancer myelodysplastic syndromes (MDS)
Last Marrow Standing: Bone Marrow Transplantation for Acquired Bone Marrow Failure Conditions Oct 2012 Curr Hematol Malig Rep myelodysplastic syndromes (MDS)
Reduced ribosomal RNA expression and increased ribosomal DNA promoter methylation in CD34+ cells of patients with myelodysplastic syndromes Oct 2012 Blood myelodysplastic syndromes (MDS)
Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Societe Francaise de Greffe de Moelle et de Therapie-Cellulaire and the Groupe-Francophone des Myelodysplasies Oct 2012 J Clin Oncol myelodysplastic syndromes (MDS)
Etiology and survival of aplastic anemia: a study based on clinical investigation Nov 2012 J Clin Lab Anal aplastic anemia
Response to pre-transplant hypomethylating agents influences the outcome of allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndromes Nov 2012 Eur J Haematol myelodysplastic syndromes (MDS)